Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 201
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #212: Delix Posts Early Efficacy Signal; NRx Wants FDA to Ban Competitors’ Ketamine; Cybin Raises $175M
Q3’25 Psychedelic Lobbying Update
Jennifer Espenscheid — Art as a Practice, Psychedelics as a Teacher
The Psychedelic News Feed: October 20 – 26, 2025
Pα+ Psychedelic Bulletin #211: AbbVie Officially Enters Psychedelics; atai-Beckley’s 5-MeO-DMT Scores Breakthrough Therapy Designation; California Bill Signed
Psychedelic Bulletin: Microdosing Study Causes a Stir; COMPASS Secures 5th US...
Numinus Receives Conditional Approval to Graduate to the Toronto Stock Exchange
Numinus Announces Departure of Stacey Wallin
PTSF86 – Ayahuasca, Chronic Pain, and Legal Psilocybin, with Payton Nyquvest...
Seelos Therapeutics Raises $20 Million in Private Placement of Senior Secured...
PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat...
Entheon Biomedical Provides Update on Clinical and Preclinical DMT Programs
Psychedelic and Mysticism: The Debate Continues
PT274 – Juan Pablo Cappello – Nue Life: Using Digital Phenotyping...
COMPASS Pathways granted fifth US patent for crystalline psilocybin
1
...
200
201
202
...
300
Page 201 of 300
